Metabolic syndrome surgery: Difference between revisions
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
[[Metabolic syndrome]] occurs in the presence of [[insulin]] resistance and accompanying [[obesity]]. It increases the risk for [[coronary heart disease]], [[diabetes]], [[fatty liver]], [[stroke]] and some [[cancer]]s. Surgical therapy is not routinely performed for metabolic syndrome. However, in cases of [[morbid obesity]] and unresponsiveness of medical therapy bariatric surgery can be performed. The beneficial effects of surgery is thought to be due to the weight loss after surgery that in turn decreases the [[insulin]] resistance. Also, increased secretion of gut hormones such as [[glucagon]]-like peptide-1 (GLP-1) accompanies the surgery and thus helps in metabolic syndrome. | [[Metabolic syndrome]] occurs in the presence of [[insulin]] resistance and accompanying [[obesity]]. It increases the risk for [[coronary heart disease]], [[diabetes]], [[fatty liver]], [[stroke]] and some [[cancer]]s. Surgical therapy is not routinely performed for metabolic syndrome. However, in cases of [[morbid obesity]] and unresponsiveness of medical therapy bariatric surgery can be performed. The beneficial effects of surgery is thought to be due to the weight loss after surgery that in turn decreases the [[insulin]] resistance. Also, increased secretion of gut hormones such as [[glucagon]]-like peptide-1 (GLP-1) accompanies the surgery and thus helps in metabolic syndrome <ref name="pmid17964919">{{cite journal| author=Kini S, Herron DM, Yanagisawa RT| title=Bariatric surgery for morbid obesity--a cure for metabolic syndrome? | journal=Med Clin North Am | year= 2007 | volume= 91 | issue= 6 | pages= 1255-71, xi | pmid=17964919 | doi=10.1016/j.mcna.2007.06.007 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17964919 }} </ref>. | ||
==See also== | ==See also== | ||
Revision as of 01:46, 29 September 2011
|
Metabolic syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Metabolic syndrome surgery On the Web |
|
American Roentgen Ray Society Images of Metabolic syndrome surgery |
|
Risk calculators and risk factors for Metabolic syndrome surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]
Overview
Metabolic syndrome occurs in the presence of insulin resistance and accompanying obesity. It increases the risk for coronary heart disease, diabetes, fatty liver, stroke and some cancers. Surgical therapy is not routinely performed for metabolic syndrome. However, in cases of morbid obesity and unresponsiveness of medical therapy bariatric surgery can be performed. The beneficial effects of surgery is thought to be due to the weight loss after surgery that in turn decreases the insulin resistance. Also, increased secretion of gut hormones such as glucagon-like peptide-1 (GLP-1) accompanies the surgery and thus helps in metabolic syndrome [1].
See also
References
- ↑ Kini S, Herron DM, Yanagisawa RT (2007). "Bariatric surgery for morbid obesity--a cure for metabolic syndrome?". Med Clin North Am. 91 (6): 1255–71, xi. doi:10.1016/j.mcna.2007.06.007. PMID 17964919.